Arcturus Therapeutics Holdings reported a net margin of -803.82% for the quarter ended Jun 2026. These financial ratios cover 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||
| EBT Margin | -2,208.49% | -649.72% | -975.76% | -79.59% | -263.79% | 74.02% | 63.35% | -494.09% | -33.96% | -37.09% | -69.58% | -34.83% | -17.09% | -131.81% | -47.91% | -32.42% | -78.41% | -404.16% | -1,403.74% | -803.82% | |||||||||||||
| EBIT Margin | -2,208.49% | -649.72% | -960.70% | -81.53% | -275.32% | 75.77% | 18.38% | -526.42% | -42.79% | -59.22% | -80.01% | -42.37% | -25.76% | -146.68% | -57.27% | -41.04% | -96.27% | -435.06% | -1,403.74% | -863.30% | |||||||||||||
| EBITDA Margin | -2,208.49% | -649.72% | -960.70% | -81.53% | -275.32% | 75.77% | 18.38% | -526.42% | -42.79% | -59.22% | -80.01% | -42.37% | -25.76% | -146.68% | -57.27% | -41.04% | -96.27% | -435.06% | -1,403.74% | -863.30% | |||||||||||||
| Operating Margin | -2,208.49% | -649.72% | -960.70% | -81.53% | -275.32% | 75.77% | 18.38% | -526.42% | -42.79% | -59.22% | -80.01% | -42.37% | -25.76% | -146.68% | -57.27% | -41.04% | -96.27% | -435.06% | -1,403.74% | -863.30% | |||||||||||||
| Net Margin | -2,208.49% | -649.72% | -977.67% | -79.59% | -263.79% | 74.02% | 63.22% | -499.79% | -35.95% | -37.85% | -70.63% | -34.43% | -16.56% | -131.80% | -47.91% | -32.44% | -78.41% | -403.91% | -1,403.74% | -803.82% | |||||||||||||
| FCF Margin | -755.81% | -752.76% | -975.40% | -135.99% | -330.55% | 97.60% | -45.54% | 479.64% | -73.96% | -4.87% | -15.25% | -61.11% | -57.22% | -1.25% | -120.06% | -20.33% | -101.06% | -224.28% | -943.28% | -672.86% | |||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 441.67M | 413.68M | 367.40M | 339.50M | 315.32M | 372.01M | 460.62M | 450.75M | 444.15M | 443.53M | 424.13M | 403.73M | 379.63M | 357.36M | 337.93M | 320.53M | 295.81M | 276.75M | 258.28M | 234.86M | |||||||||||||
| Invested CapitalInvested Cap. | 319.95M | 291.32M | 248.24M | 233.50M | 205.41M | 381.37M | 300.06M | 278.51M | 240.98M | 248.76M | |||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.02 | 0.03 | 0.04 | 0.12 | 0.16 | 0.55 | 0.61 | 0.59 | 0.67 | 0.38 | 0.29 | 0.41 | 0.42 | 0.43 | 0.43 | 0.38 | 0.33 | 0.30 | 0.21 | 0.13 | |||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||
| Debt Ratio | 0.14 | 0.16 | 0.19 | 0.19 | 0.20 | 0.25 | 0.04 | 0.05 | |||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -23.39 | -25.93 | -13.89 | -19.30 | -11.13 | 3.80 | 12.54 | -14.50 | -42.07 | -72.42 | -33.86 | -38.36 | -91.06 | -15.32 | -20.40 | -38.47 | -37.32 | -5.99 | -7.58 | -8.03 | |||||||||||||
| Price to SalesP/S | 516.60 | 168.45 | 135.76 | 15.36 | 29.37 | 2.81 | 7.93 | 72.45 | 15.13 | 27.41 | 23.91 | 13.21 | 15.08 | 20.20 | 9.77 | 12.48 | 29.27 | 24.20 | 106.47 | 64.55 | |||||||||||||
| Price to BookP/B | 4.86 | 4.28 | 3.85 | 2.44 | 2.70 | 1.67 | 1.93 | 2.67 | 2.44 | 3.04 | 3.44 | 2.55 | 2.40 | 1.91 | 1.23 | 1.53 | 2.24 | 0.81 | 1.15 | 1.11 | |||||||||||||
| Enterprise Value | 845.08M | 605.54M | 392.25M | 132.58M | 154.94M | 58.49M | 308.59M | 438.67M | 370.85M | 498.88M | 565.59M | 343.14M | 336.44M | 110.91M | 31.76M | 101.73M | 266.58M | -56.73M | 8.05M | -0.48M | |||||||||||||
| EV to EBIT | -15.70 | -16.09 | -7.79 | -6.00 | -4.21 | 0.48 | 20.91 | -7.92 | -19.20 | -27.30 | -18.60 | -16.24 | -31.33 | -3.32 | -1.89 | -8.76 | -16.14 | 1.81 | -0.28 | 0.02 | |||||||||||||
| EV to EBITDA | -15.70 | -16.09 | -7.79 | -6.00 | -4.21 | 0.48 | 20.91 | -7.92 | -19.20 | -27.30 | -18.60 | -16.24 | -31.33 | -3.32 | -1.89 | -8.76 | -16.14 | 1.81 | -0.28 | 0.02 | |||||||||||||
| Market Capitalization | 1,258.96M | 976.03M | 711.93M | 416.07M | 392.61M | 450.37M | 636.52M | 762.14M | 682.77M | 845.89M | 908.99M | 658.47M | 628.62M | 459.82M | 287.21M | 353.20M | 501.94M | 174.18M | 219.43M | 191.00M | |||||||||||||
| Price to FCFP/FCF | -68.35 | -22.38 | -13.92 | -11.29 | -8.88 | 2.88 | -17.41 | 15.11 | -20.45 | -562.42 | -156.80 | -21.61 | -26.36 | -0.00M | -8.14 | -61.37 | -28.96 | -10.79 | -11.29 | -9.59 | |||||||||||||
| EV to FCF | -45.88 | -13.88 | -7.67 | -3.60 | -3.51 | 0.37 | -8.44 | 8.69 | -11.11 | -331.70 | -97.57 | -11.26 | -14.11 | -390.51 | -0.90 | -17.68 | -15.38 | 3.52 | -0.41 | 0.02 | |||||||||||||
| EV to CFO | -50.75 | -14.25 | -8.00 | -3.60 | -3.65 | 0.36 | -8.60 | 8.63 | -11.44 | -793.13 | -101.78 | -11.38 | -14.16 | -390.51 | -0.90 | -17.68 | -15.54 | 3.50 | -0.41 | 0.02 | |||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -2,208.49% | -649.72% | -960.70% | -81.53% | -275.32% | 75.77% | 18.38% | -526.42% | -42.79% | -59.22% | -80.01% | -42.37% | -25.76% | -146.68% | -57.27% | -41.04% | -96.27% | -435.06% | -1,403.74% | -863.30% | |||||||||||||
| Return on Capital Employed [ROCE]ROCE | -60.69% | -64.57% | -75.19% | -66.44% | -61.35% | 4.97% | 20.87% | 12.22% | 17.26% | -21.63% | -39.97% | -28.56% | -25.97% | -32.78% | -28.45% | -26.49% | -29.67% | -31.73% | -39.46% | -50.81% | |||||||||||||
| Return on Invested Capital [ROIC]ROIC | -28.82% | -33.32% | |||||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -44.44% | -49.04% | -53.47% | -48.39% | -46.22% | 2.83% | 24.44% | 18.09% | 22.65% | -6.70% | -25.31% | -17.81% | -16.49% | -22.64% | -20.17% | -18.77% | -22.55% | -23.77% | -31.22% | -40.55% |